Streetbeat News

Stock Prices

GILD

PFE

VTRS

The most accurate Wall Street analysts recommend holding three high-yielding healthcare stocks: Pfizer Inc. (PFE), Viatris Inc. (VTRS), and Gilead Sciences, Inc. (GILD). These stocks have dividend yields of 5.07%, 4.94%, and 4.01% respectively. Recent news for these companies include the European Commission's approval of ViiV Healthcare's Apretude for HIV prevention, Viatris' Q2 sales of $3.91 billion, and Gilead Sciences' early data from its Phase 2 EVOKE-02 study.

Portfolio Pulse from Lisa Levin

September 27, 2023 | 1:03 pm

MAA

PEAK

RDFN

Z

The article lists four real estate stocks that are considered oversold and may present buying opportunities. These include Healthpeak Properties, Inc. (PEAK), Mid-America Apartment Communities, Inc. (MAA), Redfin Corporation (RDFN), and Zillow Group, Inc. (Z). The stocks are considered oversold based on their Relative Strength Index (RSI) values, which are all below or near 30.

Portfolio Pulse from Lisa Levin

September 27, 2023 | 1:03 pm

VRPX

Virpax Pharmaceuticals has announced the results of dose escalation studies for Probudur. The studies compared Probudur to Exparel, with Probudur demonstrating three to five times longer efficacy than Exparel.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 1:02 pm

ICPT

Over the past 3 months, 5 analysts have published their opinion on Intercept Pharma (NASDAQ:ICPT) stock. The average price target is $19.2, implying an upside from the current price of $18.71. The average price target has increased by 22.53% over the past month.

Portfolio Pulse from Benzinga Insights

September 27, 2023 | 1:01 pm

VRNT

Verint Systems (NASDAQ:VRNT) has received mixed analyst ratings in the last quarter, with 2 bullish, 3 somewhat bullish, and 1 indifferent. The average price target is $36.83, representing an upside from the current price of $23.93. However, this is a 23.59% decrease from the previous average price target of $48.20.

Portfolio Pulse from Benzinga Insights

September 27, 2023 | 1:01 pm

TNL

In the last quarter, Travel+Leisure (NYSE:TNL) received 2 bullish and 2 indifferent analyst ratings. The company's average 12-month price target is $49.75, representing a 3.08% decrease from the previous average price target of $51.33.

Portfolio Pulse from Benzinga Insights

September 27, 2023 | 1:00 pm

GENI

Analysts have given Genius Sports (NYSE:GENI) predominantly bullish ratings in the last quarter, with an average price target of $9.67, a 23.03% increase from the previous average price target of $7.86. No bearish or indifferent ratings were observed.

Portfolio Pulse from Benzinga Insights

September 27, 2023 | 1:00 pm

BURL

Burlington Stores (NYSE:BURL) has received various analyst ratings in the last quarter, with 1 bullish, 5 somewhat bullish, and 2 indifferent. The average price target is $202.75, indicating potential upside from the current price of $132.4. However, this average has decreased by 4.81% from the previous target of $213.00.

Portfolio Pulse from Benzinga Insights

September 27, 2023 | 1:00 pm

CLSK

MARA

RIOT

Crypto mining stocks Marathon Digital Holdings Inc (NASDAQ:MARA), Riot Platforms Inc (NASDAQ:RIOT) and CleanSpark Inc (NASDAQ:CLSK) are rising alongside the price of Bitcoin. The rise is attributed to continued optimism surrounding a potential spot ETF for Bitcoin. Four members of the House Financial Services Committee have called on SEC chair Gary Gensler to approve ETF applications.

Portfolio Pulse from Adam Eckert

September 27, 2023 | 12:55 pm

FFIE

Faraday Future Intelligent Electric (FFIE) is in active discussions with strategic investors to alleviate its funding issues. The company also plans to deliver additional FF 91 2.0 Futurist Alliance vehicles to top-tier users this year, according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 12:54 pm